A study published in *Aging Cell* reveals that the APOE2 variant promotes DNA repair pathways in neurons, enabling them to resist cellular senescence linked to neurodegenerative diseases like Alzheimer's.

Researchers from the Buck Institute for Research on Aging discovered that APOE2 modulates gene expression to enhance DNA damage response mechanisms, potentially delaying age-related cognitive decline.The findings suggest that targeting these genetic pathways could lead to therapies for Alzheimer’s and other aging-associated conditions.

The study used human neurons and mouse models to demonstrate that APOE2 reduces the accumulation of toxic proteins like tau, which are hallmarks of Alzheimer’s pathology.This work underscores the role of genetics in neurodegeneration and opens avenues for personalized medicine targeting specific alleles.

The research also highlights the importance of understanding how genetic variations influence cellular resilience, offering hope for interventions that slow or reverse age-related brain deterioration.